A biotech startup called Geno.Me has landed $400,000 in seed funding from Gateway Capital, an early-stage investment firm based in Milwaukee.
The company’s platform connects electronic health record data with genomic information from services like 23andMe, MyChart and Anscestry.com in hopes of furthering medical research. Individuals who share their data with the platform are compensated on a m...
Please log in to access subscriber content.
If you don't have a subscription, click
here for a WisPolitics free trial and to view the different subscription options.
